Targeted Type To Account for Larger Share in Lipidomics Equipment Market During 2022-2028.

The lipidomics equipment market is expected to grow from US$ 1,025.38 million in 2021 to US$ 2,662.67 million by 2028; it is estimated to grow at a CAGR of 14.7% from 2022 to 2028. Major factors driving market growth include technological advancements in mass spectrometry and the growing application of lipidomics in biomedical sciences. However, premium product pricing limits the market growth.

Growing Applications of Lipidomics in Biomedical Science Offers Lucrative Opportunities for Lipidomics Equipment Market Players Lipidomics, an emerging discipline of biomedical sciences, involves the characterization of complex lipidomes. It is a quantitative and complete depiction of a set of lipid species present in an organism. The lipidome characterization is based on a system-level quantitation and the detection of several networks & pathways of cellular lipids, along with their interaction with other moieties and proteins. Determining lipid profiles and comparing the profiles obtained for two physiologically linked conditions can help understand lipid metabolism pathways, which further can be employed to develop diagnostic methods for cancer, cardiovascular disorders, eye diseases, and other diseases.

In March 2022, Lipotype GmbH, Lund University, and the Twincore Centre for Experimental and Clinical Infection Research, together, demonstrated that the measurement of lipids in the blood could be used for predicting the risk of type 2 diabetes and cardiovascular disorders. Researchers from this group believe lipidome analysis is likely to emerge as a faster and cheaper method for diagnosing these diseases compared to traditional assays. In February 2022, researchers from the Peking University Health Science Center in Beijing performed liquid chromatography-mass spectrometry (LCMS)-based targeted lipidomics assay on 311 participants. This study represents the potential application of Lung Cancer Artificial Intelligence Detector v2.0 for lipidomics-based large-scale population screening, particularly for populations with a high risk of lung cancer. This study identified nine lipid profiles associated with early-stage lung cancer.

The outbreak of COVID-19 had a slightly negative impact on the growth of the lipidomics equipment market as production facilities for major manufacturers were closed. Most key players tried to supply their products to the customers through various channels but are facing problems due to the limited manufacturing and disturbance caused by the pandemic. For instance, the annual sales of Bruker Corporation have been affected significantly due to coronavirus pandemic. The company's first-quarter 2020 results reflected a decline in both reported and organic revenue, mainly due to COVID-19 disruptions. Various conferences related to lipidomics equipment are being conducted through webinars. Hence, it is expected to boost the market's growth during the forecast period.

Based on type, the global Lipidomics Equipment market is bifurcated into targeted and untargeted. The targeted segment accounted for the largest market share in 2021 and is expected to register the highest CAGR from 2022 to 2028. Based on offerings, the market is MS-based lipidomics techniques, assays for lipid metabolism, lipid flux using heavy isotope-labeled precursors, software & services, and others. The MS-based lipidomics techniques segment is further subsegmented into mass spectrometers equipped with ion sources (turbo-) ESI/nano-ESI/APCI, autosamplers, micropumps, UV detectors, UPLC, variable-length fluorescence detectors, and others. In 2021, the MS-based lipidomics techniques segment held the largest market share; however, the software & services segment is expected to grow at the fastest CAGR of 15.4% during the coming years. Based on services, the global lipidomics equipment market has been segmented into biomarker identification, bioinformatic analysis & data interpretation, molecular analysis of a broad spectrum of phospholipids (lipid fingerprinting), analysis & identification of unusual lipids, semiquantitative & quantitative analysis, lipid flux studies, and others. Based on end user, the global Lipidomics Equipment market is segmented into molecular research, cellular research, clinical research, tissue & organ research, data research, organism research, technical services & prototyping, production, and others. In 2021, the molecular research segment held the largest market share; however, the clinical research segment is expected to grow at the fastest CAGR of 15.2% during the coming years.

Thermofisher Scientific; Creative Proteomics; IonBench; Shimadzu Europe GMbH; Bruker; Agilent Technologies Inc; PerkinElmer, Inc.; Sciex; Metabolon, Inc.; and Cayman Chemical are among the leading companies operating in the lipidomics equipment market.

Based on geography, the lipidomics equipment market is primarily segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa (MEA). The market in North America is further segmented into the US, Canada, and Mexico. The European lipidomics equipment market is subsegmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Asia Pacific lipidomics equipment market is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The market in South & Central America lipidomics equipment market is subsegmented into Brazil, Argentina, and the Rest of South & Central America. The lipidomics equipment market in the Middle East & Africa is further segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa .

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com